Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Akcea Therapeutics
Akcea Therapeutics
(AKCA)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Tegsedi
Inotersen
2018-10-05
2025-2031
Amyloidosis
,
Familial amyloid neuropathies
Waylivra
Volanesorsen
2019-05-03
Hyperlipoproteinemia type i
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Volanesorsen
cardiovascular abnormalities
,
hyperlipoproteinemia type i
,
hyperlipidemias
,
hyperlipoproteinemia type v
,
syndrome
,
hyperlipoproteinemias
,
lipodystrophy
,
familial partial lipodystrophy
,
hypertriglyceridemia
Inotersen
amyloidosis
,
familial amyloid neuropathies
,
pregnancy
Pelacarsen
renal insufficiency
,
cardiovascular diseases
,
hyperlipidemias
,
hyperlipoproteinemias
VUPANORSEN
hypertriglyceridemia
,
hypercholesterolemia
,
hyperlipoproteinemia type ii
,
lipodystrophy
,
familial partial lipodystrophy
,
liver diseases
,
type 2 diabetes mellitus
,
diabetes mellitus
,
non-alcoholic fatty liver disease
,
fatty liver
,
hyperlipidemias
,
hyperlipoproteinemia type v
,
syndrome
,
hyperlipoproteinemia type i
,
hyperlipoproteinemias
,
homozygous familial hypercholesterolemia
Endocrine
type 2 diabetes mellitus
Trinessa
healthy volunteers/patients
,
coronary artery disease
,
electrocardiography
,
overactive urinary bladder
,
endometriosis
,
cough
,
hot flashes
,
multiple endocrine neoplasia type 1
,
tuberculosis
,
infections
,
communicable diseases
,
intraabdominal infections
,
abdominal abscess
,
pelvic infection
,
pelvic inflammatory disease
,
diabetic foot
,
wound infection
,
ulcer
,
aspiration pneumonia
,
lung abscess
,
contraception
,
sepsis
,
septic shock
,
respiratory tract infections
,
lung diseases
,
acute cholecystitis
,
chronic bronchitis
,
pneumonia
,
bronchitis
,
sinusitis
,
abscess
,
community-acquired pneumonia
,
acute disease
,
liver abscess
,
pyogenic liver abscess
,
maxillary sinusitis
,
bacterial infections
,
rhinosinusitis
,
disease progression
,
wounds and injuries
,
chemical and drug induced liver injury
,
tonsillitis
,
peritonitis
,
bacterial skin diseases
,
bronchial diseases
Fluoroquinolone
healthy volunteers/patients
Thienopyridine
healthy volunteers/patients
,
cardiovascular diseases
,
blood platelet disorders
,
ischemic stroke
,
transient ischemic attack
,
atherosclerosis
,
percutaneous coronary intervention
,
ischemia
,
thrombosis
,
congenital heart defects
,
atrial fibrillation
,
unstable angina
,
hemorrhage
,
coronary artery bypass
,
arterial occlusive diseases
,
coronary artery disease
,
acute coronary syndrome
,
vascular diseases
,
myocardial infarction
,
myocardial ischemia
,
coronary disease
,
coronary stenosis
,
coronary restenosis
,
stroke
,
migraine disorders
,
atrial heart septal defects
,
metabolic syndrome
,
peripheral arterial disease
Tqj230
cardiovascular diseases
,
hyperlipidemias
,
hyperlipoproteinemias
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use